Shopping Cart
- Remove All
Your shopping cart is currently empty
PST3.1a is a selective inhibitor of Mannoside acetyl glucosaminyltransferase 5 (MGAT5), used for studying glioblastoma multiforme (GBM). PST3.1a inhibits TGF-βR and FAK signalling associated with doublecortin (DCX), increases OLIG2 expression, and suppresses the invasion and proliferation of GBM initiator cells (GICs).

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $238 | Backorder | |
| 5 mg | $593 | Backorder | |
| 10 mg | $846 | 10-14 weeks | |
| 25 mg | $1,460 | Backorder | |
| 50 mg | $2,620 | 10-14 weeks |
| Description | PST3.1a is a selective inhibitor of Mannoside acetyl glucosaminyltransferase 5 (MGAT5), used for studying glioblastoma multiforme (GBM). PST3.1a inhibits TGF-βR and FAK signalling associated with doublecortin (DCX), increases OLIG2 expression, and suppresses the invasion and proliferation of GBM initiator cells (GICs). |
| Targets&IC50 | MGAT5:2 μM |
| Synonyms | PST3 1a |
| Molecular Weight | 544.57 |
| Formula | C32H33O6P |
| Cas No. | 1096144-06-7 |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.